Finance

Lists
BETA:NSE
Beta Drugs Ltd
2 055,00 INR
+0,10%
(+2,00) 1D
1 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for BETA...
Open
2 030,00 INR
High
2 088,50 INR
Low
2 020,00 INR
Mkt. cap
22,78 მლრდ.
Avg. vol.
19,50 ათ.
Volume
8,70 ათ.
P/E ratio
46,49
52-wk high
2 807,90 INR
52-wk low
990,10 INR
EPS
44,20 INR
No. of employees
455
Open
2 030,00 INR
High
2 088,50 INR
Low
2 020,00 INR
Mkt. cap
22,78 მლრდ.
Avg. vol.
19,50 ათ.
Volume
8,70 ათ.
P/E ratio
46,49
52-wk high
2 807,90 INR
52-wk low
990,10 INR
EPS
44,20 INR
No. of employees
455
News stories
From web sources and news partners
About Beta Drugs Ltd
CEO-
Employees455
Founded1985
Headquarters-
SectorPharmaceutical industry
Websitebetadrugslimited.com
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
ივნ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
1,00 მლრდ.
872,68 მლნ.
939,65 მლნ.
1,26 მლრდ.
Cost of goods sold
497,43 მლნ.
360,44 მლნ.
417,74 მლნ.
545,16 მლნ.
Cost of revenue
497,43 მლნ.
360,44 მლნ.
417,74 მლნ.
545,16 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
160,23 მლნ.
168,23 მლნ.
237,57 მლნ.
203,96 მლნ.
Operating expense
344,85 მლნ.
386,27 მლნ.
393,09 მლნ.
480,11 მლნ.
Total operating expenses
842,28 მლნ.
746,71 მლნ.
810,84 მლნ.
1,03 მლრდ.
Operating income
159,79 მლნ.
125,97 მლნ.
128,81 მლნ.
230,22 მლნ.
Other non operating income
29,88 მლნ.
23,10 მლნ.
-72,55 მლნ.
15,83 მლნ.
EBT including unusual items
156,47 მლნ.
104,72 მლნ.
118,31 მლნ.
220,42 მლნ.
EBT excluding unusual items
156,47 მლნ.
104,72 მლნ.
118,31 მლნ.
220,42 მლნ.
Income tax expense
39,48 მლნ.
19,55 მლნ.
27,83 მლნ.
55,56 მლნ.
Effective tax rate
25,23%
18,67%
23,52%
25,21%
Other operating expenses
147,36 მლნ.
174,15 მლნ.
107,55 მლნ.
232,69 მლნ.
Net income
116,99 მლნ.
85,17 მლნ.
90,49 მლნ.
158,02 მლნ.
Net profit margin
11,67%
9,76%
9,63%
12,59%
Earnings per share
-
-
-
-
Interest and investment income
-
-
98,60 მლნ.
-
Interest expense
-33,20 მლნ.
-44,34 მლნ.
-36,55 მლნ.
-25,63 მლნ.
Net interest expenses
-33,20 მლნ.
-44,34 მლნ.
62,05 მლნ.
-25,63 მლნ.
Depreciation and amortization charges
37,26 მლნ.
43,89 მლნ.
47,97 მლნ.
43,46 მლნ.
EBITDA
188,23 მლნ.
154,40 მლნ.
167,33 მლნ.
273,10 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები